Monte Rosa Therapeutics (GLUE) Earnings Date & Reports
Get AI intraday signals
A.I. Advisor
published Earnings
GLUE is expected to report earnings to rise 53.86% to -44 cents per share on March 13
Q4'24
Est.
$-0.45
Q3'24
Beat
by $0.18
Q2'24
Beat
by $0.09
Q1'24
Beat
by $0.06
Q4'23
Missed
by $0.19
The last earnings report on November 07 showed earnings per share of -28 cents, beating the estimate of -46 cents. With 661.79K shares outstanding, the current market capitalization sits at 605.77M.